Cited by 144Gestational Diabetes Research and ManagementEpigenetics and DNA MethylationBirth, Development, and Health

Increased global placental DNA methylation levels are associated with gestational diabetes

Open access
Reichetzeder, C., Dwi Putra, S. E., Pfab, T., Slowinski, T., Neuber, C., Kleuser, B., Hocher, B.·2016·Clinical Epigenetics

Abstract

BACKGROUND: Gestational diabetes mellitus (GDM) is associated with adverse pregnancy outcomes. It is known that GDM is associated with an altered placental function and changes in placental gene regulation. More recent studies demonstrated an involvement of epigenetic mechanisms. So far, the focus regarding placental epigenetic changes in GDM was set on gene-specific DNA methylation analyses. Studies that robustly investigated placental global DNA methylation are lacking. However, several studies showed that tissue-specific alterations in global DNA methylation are independently associated with type 2 diabetes. Thus, the aim of this study was to characterize global placental DNA methylation by robustly measuring placental DNA 5-methylcytosine (5mC) content and to examine whether differences in placental global DNA methylation are associated with GDM. METHODS: Global DNA methylation was quantified by the current gold standard method, LC-MS/MS. In total, 1030 placental samples were analyzed in this single-center birth cohort study. RESULTS: Mothers with GDM displayed a significantly increased global placental DNA methylation (3.22 ± 0.63 vs. 3.00 ± 0.46 %; p = 0.013; ±SD). Bivariate logistic regression showed a highly significant positive correlation between global placental DNA methylation and the presence of GDM (p = 0.0009). Quintile stratification according to placental DNA 5mC levels revealed that the frequency of GDM was evenly distributed in quintiles 1-4 (2.9-5.3 %), whereas the frequency in the fifth quintile was significantly higher (10.7 %; p = 0.003). Bivariate logistic models adjusted for maternal age, BMI, ethnicity, recurrent miscarriages, and familiar diabetes predisposition clearly demonstrated an independent association between global placental DNA hypermethylation and GDM. Furthermore, an ANCOVA model considering known predictors of DNA methylation substantiated an independent association between GDM and placental DNA methylation. CONCLUSIONS: This is the first study that employed a robust quantitative assessment of placental global DNA methylation in over a thousand placental samples. The study provides large scale evidence that placental global DNA hypermethylation is associated with GDM, independent of established risk factors.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13148-016-0247-9

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • DNA methylation is important in the regulation of gene expression associated with metabolic disturbances in pregnant women and in the metabolic programming of the fetus in the setting of GDM-induced hyperglycemia.

    “A growing body of research provides evidence of the importance of DNA methylation in the regulation of gene expression associated with metabolic disturbances in pregnant women and in the metabolic programming of the fetus in the setting of GDM-induced hyperglycemia [56,57,58].”

    From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [57]

    The Background (page unavailable) links GDM to altered placental gene regulation and epigenetic mechanisms, and separately says that fetal exposure to GDM might contribute to later metabolic programming. The Discussion reports an association between placental DNA methylation and GDM, but the paper does not establish that methylation regulates gene expression in pregnant women or drives fetal metabolic programming under GDM-induced hyperglycemia. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Hypermethylation is associated with developmental defects, such as gestational diabetes and Down's syndrome.

    “Moreover, hypermethylation is associated with developmental defects, such as gestational diabetes and Down’s syndrome [181, 182].”

    From Air pollution and children’s health—a review of adverse effects associated with prenatal exposure from fine to ultrafine particulate matter (2021) · cites this paper as [181]

    The Results and Conclusions report an association between increased global placental DNA methylation and gestational diabetes. The paper does not address Down’s syndrome or establish hypermethylation as associated with developmental defects as a category; it also leaves the direction of the relationship with gestational diabetes unresolved. The indexed passages have no page numbers. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • GDM is associated with placenta global DNA hypermethylation.

    “Some recent studies have reported that GDM is associated with placenta global DNA hypermethylation [154].”

    From The Pathophysiology of Gestational Diabetes Mellitus (2018) · cites this paper as [154]

  • Mothers with GDM displayed significantly increased global placental DNA methylation (3.22 ± 0.63 vs. 3.00 ± 0.46%, p = 0.013).

    “Mothers with GDM displayed a significantly increased global placental DNA methylation (3.22 ± 0.63 vs. 3.00 ± 0.46% (±SD), p = 0.013) [57].”

    From Gestational Diabetes Mellitus—Recent Literature Review (2022) · cites this paper as [57]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 54

  1. [1]Lappas M Hiden U Desoye G Froehlich J Hauguel-de Mouzon S Jawerbaum A The role of oxidative stress in the pathophysiology of gestational diabetes mellitus Antioxid Redox Signal 2011 15 3061 100 10.1089/ars.2010.3765 21675877 · DOI · Paper page
  2. [2]Schneider S Bock C Wetzel M Maul H Loerbroks A The prevalence of gestational diabetes in advanced economies J Perinat Med 2012 40 511 20 10.1515/jpm-2012-0015 23120759 · DOI
  3. [3]Coustan DR Gestational diabetes mellitus Clin Chem 2013 59 1310 21 10.1373/clinchem.2013.203331 23536513 · DOI
  4. [5]Gauster M Desoye G Tötsch M Hiden U The placenta and gestational diabetes mellitus Curr Diab Rep 2012 12 16 23 10.1007/s11892-011-0244-5 22102097 · DOI
  5. [6]Reece EA Leguizamón G Wiznitzer A Gestational diabetes: the need for a common ground Lancet 2009 373 1789 97 10.1016/S0140-6736(09)60515-8 19465234 · DOI
  6. [7]Schaefer-Graf P-DD med UM, Kautzky-Willer U-PD med A. Diabetes mellitus und Schwangerschaft. In: Schneider PD med H, Husslein U-PD med P-W, Schneider U-PD med KTM, editors. Die Geburtshilfe. Berlin: Springer; 2011. p. 435–56.
  7. [8]Gabbay-Benziv R Baschat AA Gestational diabetes as one of the “great obstetrical syndromes”—the maternal, placental, and fetal dialog Best Pract Res Clin Obstet Gynaecol 2015 29 150 5 10.1016/j.bpobgyn.2014.04.025 25225057 · DOI
  8. [9]Nomura Y Lambertini L Rialdi A Lee M Mystal EY Grabie M Global methylation in the placenta and umbilical cord blood from pregnancies with maternal gestational diabetes, preeclampsia, and obesity Reprod Sci 2014 21 131 7 10.1177/1933719113492206 23765376 PMC3857768 · DOI
  9. [10]Bouchard L Hivert M-F Guay S-P St-Pierre J Perron P Brisson D Placental adiponectin gene DNA methylation levels are associated with mothers’ blood glucose concentration Diabetes 2012 61 1272 80 10.2337/db11-1160 22396200 PMC3331769 · DOI · Paper page
  10. [11]Ruchat S-M Houde A-A Voisin G St-Pierre J Perron P Baillargeon J-P Gestational diabetes mellitus epigenetically affects genes predominantly involved in metabolic diseases Epigenetics 2013 8 935 43 10.4161/epi.25578 23975224 PMC3883770 · DOI
  11. [12]Finer S Mathews C Lowe R Smart M Hillman S Foo L Maternal gestational diabetes is associated with genome-wide DNA methylation variation in placenta and cord blood of exposed offspring Hum Mol Genet 2015 24 11 3021 9 10.1093/hmg/ddv013 25634562 · DOI
  12. [13]Binder AM LaRocca J Lesseur C Marsit CJ Michels KB Epigenome-wide and transcriptome-wide analyses reveal gestational diabetes is associated with alterations in the human leukocyte antigen complex Clin Epigenetics 2015 7 79 10.1186/s13148-015-0116-y 26244062 PMC4524439 · DOI
  13. [14]Busche S Shao X Caron M Kwan T Allum F Cheung WA Population whole-genome bisulfite sequencing across two tissues highlights the environment as the principal source of human methylome variation Genome Biol 2015 16 290 10.1186/s13059-015-0856-1 26699896 PMC4699357 · DOI
  14. [15]Patrushev LI Kovalenko TF Functions of noncoding sequences in mammalian genomes Biochemistry (Mosc) 2014 79 1442 69 10.1134/S0006297914130021 25749159 · DOI
  15. [16]Gregory TR Synergy between sequence and size in large-scale genomics Nat Rev Genet 2005 6 699 708 10.1038/nrg1674 16151375 · DOI · Paper page
  16. [17]Gelfman S Cohen N Yearim A Ast G DNA-methylation effect on cotranscriptional splicing is dependent on GC architecture of the exon–intron structure Genome Res 2013 23 789 99 10.1101/gr.143503.112 23502848 PMC3638135 · DOI
  17. [18]Lev Maor G Yearim A Ast G The alternative role of DNA methylation in splicing regulation Trends Genet 2015 31 274 80 10.1016/j.tig.2015.03.002 25837375 · DOI
  18. [19]Reddington JP Pennings S Meehan RR Non-canonical functions of the DNA methylome in gene regulation Biochem J 2013 451 13 23 10.1042/BJ20121585 23489368 · DOI
  19. [20]Kurdyukov S, Bullock M. DNA methylation analysis: choosing the right method. Biology (Basel) [Internet]. 2016 [cited 2016 Jun 11];5. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4810160/ PMC4810160 26751487
  20. [21]Schroeder DI Jayashankar K Douglas KC Thirkill TL York D Dickinson PJ Early developmental and evolutionary origins of gene body DNA methylation patterns in mammalian placentas PLoS Genet 2015 11 10.1371/journal.pgen.1005442 26241857 PMC4524645 · DOI
  21. [22]Chatterjee A, Macaulay EC, Rodger EJ, Stockwell PA, Parry MF, Roberts HE, Slatter TL, Hung NA, Devenish CJ, Morison IM. Placental Hypomethylation Is More Pronounced in Genomic Loci Devoid of Retroelements. G3 (Bethesda). 2016;6(7):1911–21. doi:10.1534/g3.116.030379. PMC4938645 27172225 · DOI
  22. [23]Bianco-Miotto T Mayne BT Buckberry S Breen J Lopez CMR Roberts CT Recent progress towards understanding the role of DNA methylation in human placental development Reproduction 2016 152 R23 30 10.1530/REP-16-0014 27026712 PMC5064761 · DOI
  23. [24]Liu J, Hesson LB, Ward RL. Liquid Chromatography Tandem Mass Spectrometry for the Measurement of Global DNA Methylation and Hydroxymethylation. Journal of Proteomics & Bioinformatics [Internet]. Available from: http://www.omicsonline.org/proteomics-bioinformatics-abstract.php?abstract_id=15772
  24. [25]Tajuddin SM Amaral AFS Fernandez AF Rodriguez-Rodero S Rodriguez RM Moore LE Genetic and non-genetic predictors of LINE-1 methylation in leukocyte DNA Environ Health Perspect 2013 121 650 6 23552396 PMC3672919
  25. [26]Boeke CE Baccarelli A Kleinman KP Burris HH Litonjua AA Rifas-Shiman SL Gestational intake of methyl donors and global LINE-1 DNA methylation in maternal and cord blood: prospective results from a folate-replete population Epigenetics 2012 7 253 60 10.4161/epi.7.3.19082 22430801 PMC3335948 · DOI
  26. [27]Lesseur C Armstrong DA Paquette AG Li Z Padbury JF Marsit CJ Maternal obesity and gestational diabetes are associated with placental leptin DNA methylation Am J Obstet Gynecol 2014 211 6 654.e1-9 10.1016/j.ajog.2014.06.037 24954653 PMC4254188 · DOI
  27. [28]Fuke C Shimabukuro M Petronis A Sugimoto J Oda T Miura K Age related changes in 5-methylcytosine content in human peripheral leukocytes and placentas: an HPLC-based study Ann Hum Genet 2004 68 196 204 10.1046/j.1529-8817.2004.00081.x 15180700 · DOI
  28. [29]Lisanti S, Omar WAW, Tomaszewski B, De Prins S, Jacobs G, Koppen G, et al. Comparison of methods for quantification of global DNA methylation in human cells and tissues. PLoS One. 2013;8. PMC3832524 24260150
  29. [30]Maghbooli Z Larijani B Emamgholipour S Amini M Keshtkar A Pasalar P Aberrant DNA methylation patterns in diabetic nephropathy J Diabetes Metab Disord 2014 13 69 10.1186/2251-6581-13-69 25028646 PMC4099150 · DOI
  30. [31]Simar D Versteyhe S Donkin I Liu J Hesson L Nylander V DNA methylation is altered in B and NK lymphocytes in obese and type 2 diabetic human Metab Clin Exp 2014 63 1188 97 10.1016/j.metabol.2014.05.014 24996265 · DOI
  31. [32]Zhao J Goldberg J Bremner JD Vaccarino V Global DNA methylation is associated with insulin resistance: a monozygotic twin study Diabetes 2012 61 542 6 10.2337/db11-1048 22210312 PMC3266395 · DOI
  32. [33]Maghbooli Z Hossein-Nezhad A Larijani B Amini M Keshtkar A Global DNA methylation as a possible biomarker for diabetic retinopathy Diabetes Metab Res Rev 2014 31 2 183 9 10.1002/dmrr.2584 25069700 · DOI
  33. [34]Maghbooli Z Hossein-Nezhad A Larijani B Pasalar P Keshtkar AA Association between alterations in global DNA methylation and predisposing factors in diabetes: a high pressure liquid chromatography based study Minerva Med 2015 106 221 31 25078329
  34. [35]Maghbooli Z Hossein-nezhad A Larijani B Amini M Keshtkar A Global DNA methylation as a possible biomarker for diabetic retinopathy Diabetes Metab Res Rev 2015 31 183 9 10.1002/dmrr.2584 25069700 · DOI
  35. [36]Pearce MS McConnell JC Potter C Barrett LM Parker L Mathers JC Global LINE-1 DNA methylation is associated with blood glycaemic and lipid profiles Int J Epidemiol 2012 41 210 7 10.1093/ije/dys020 22422454 PMC3304536 · DOI
  36. [37]Terry MB Delgado-Cruzata L Vin-Raviv N Wu HC Santella RM DNA methylation in white blood cells: association with risk factors in epidemiologic studies Epigenetics 2011 6 828 37 10.4161/epi.6.7.16500 21636973 PMC3154425 · DOI
  37. [38]Kim YO Li C Sun BK Kim JS Lim SW Choi BS Preconditioning with 1,25-dihydroxyvitamin D3 protects against subsequent ischemia-reperfusion injury in the rat kidney Nephron Exp Nephrol 2005 100 e85 94 10.1159/000084574 15775722 · DOI
  38. [39]Walters RJ Williamson EJ English DR Young JP Rosty C Clendenning M Association between hypermethylation of DNA repetitive elements in white blood cell DNA and early-onset colorectal cancer Epigenetics 2013 8 748 55 10.4161/epi.25178 23804018 PMC3781194 · DOI
  39. [40]Neale RE Clark PJ Fawcett J Fritschi L Nagler BN Risch HA Association between hypermethylation of DNA repetitive elements in white blood cell DNA and pancreatic cancer Cancer Epidemiol 2014 38 576 82 10.1016/j.canep.2014.08.006 25201440 · DOI
  40. [41]Liao LM, Brennan P, van Bemmel DM, Zaridze D, Matveev V, Janout V, et al. LINE-1 methylation levels in leukocyte DNA and risk of renal cell cancer. PLoS One. 2011;6. PMC3208631 22076155
  41. [42]Moran LJ Noakes M Clifton PM Norman RJ Fenech MF Genome instability is increased in lymphocytes of women with polycystic ovary syndrome and is correlated with insulin resistance Mutat Res 2008 639 55 63 10.1016/j.mrfmmm.2007.11.007 18178226 · DOI
  42. [43]Attia SM Helal GK Alhaider AA Assessment of genomic instability in normal and diabetic rats treated with metformin Chem Biol Interact 2009 180 296 304 10.1016/j.cbi.2009.03.001 19497428 · DOI
  43. [44]Binici DN Karaman A Coşkun M Oğlu AU Uçar F Genomic damage in patients with type-2 diabetes mellitus Genet Couns 2013 24 149 56 24032284
  44. [45]Rani V Deep G Singh RK Palle K Yadav UCS Oxidative stress and metabolic disorders: pathogenesis and therapeutic strategies Life Sci 2016 148 183 93 10.1016/j.lfs.2016.02.002 26851532 · DOI
  45. [46]Milic M Frustaci A Del Bufalo A Sánchez-Alarcón J Valencia-Quintana R Russo P DNA damage in non-communicable diseases: a clinical and epidemiological perspective Mutat Res 2015 776 118 27 10.1016/j.mrfmmm.2014.11.009 26255943 · DOI
  46. [47]Dong D Yu J Wu Y Fu N Villela NA Yang P Maternal diabetes triggers DNA damage and DNA damage response in neurulation stage embryos through oxidative stress Biochem Biophys Res Commun 2015 467 407 12 10.1016/j.bbrc.2015.09.137 26427872 PMC4618162 · DOI
  47. [48]Wei D Loeken MR Increased DNA methyltransferase 3b (Dnmt3b)-mediated CpG island methylation stimulated by oxidative stress inhibits expression of a gene required for neural tube and neural crest development in diabetic pregnancy Diabetes 2014 63 3512 22 10.2337/db14-0231 24834974 PMC4171658 · DOI
  48. [49]Hai Z Zuo W Aberrant DNA methylation in the pathogenesis of atherosclerosis Clin Chim Acta 2016 456 69 74 10.1016/j.cca.2016.02.026 26944567 · DOI
  49. [50]Williams KT Schalinske KL Tissue-specific alterations of methyl group metabolism with DNA hypermethylation in the Zucker (type 2) diabetic fatty rat Diabetes Metab Res Rev 2012 28 123 31 10.1002/dmrr.1281 21818837 · DOI
  50. [51]Zhong J, Xu C, Reece EA, Yang P. The green tea polyphenol EGCG alleviates maternal diabetes-induced neural tube defects by inhibiting DNA hypermethylation. Am J Obstet Gynecol. 2016. doi:10.1016/j.ajog.2016.03.009. PMC5270539 26979632 · DOI
  51. [52]Fang MZ Wang Y Ai N Hou Z Sun Y Lu H Tea polyphenol (−)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines Cancer Res 2003 63 7563 70 14633667
  52. [53]Legeay S Rodier M Fillon L Faure S Clere N Epigallocatechin gallate: a review of its beneficial properties to prevent metabolic syndrome Nutrients 2015 7 5443 68 10.3390/nu7075230 26198245 PMC4517007 · DOI
  53. [54]Liu L Zhang X Rong C Rui C Ji H Qian Y Distinct DNA methylomes of human placentas between pre-eclampsia and gestational diabetes mellitus Cell Physiol Biochem 2014 34 1877 89 10.1159/000366386 25503509 · DOI
  54. [56]Dwi Putra SE Neuber C Reichetzeder C Hocher B Kleuser B Analysis of genomic DNA methylation levels in human placenta using liquid chromatography-electrospray ionization tandem mass spectrometry Cell Physiol Biochem 2014 33 945 52 10.1159/000358666 24713853 · DOI

Cited by

Sorted by citations

Authors
Reichetzeder, C., Dwi Putra, S. E., Pfab, T., Slowinski, T., Neuber, C., Kleuser, B., & Hocher, B.
Affiliations
  • University of Potsdam (DE)
  • Charité – Universitätsmedizin Berlin (DE)
  • Hunan Normal University (CN)
Corresponding author
Hocher, B.
Venue
Clinical Epigenetics
Published
2016-07-26
Volume
8
Issue
1
Pages
82-82
ISSN
  • 1868-7075 (ISSN-L)
  • 1868-7083
OpenAlex
W2502871139
Cited by
144
References
1
Citations by year
2026: 7 · 2025: 9 · 2024: 9 · 2023: 22 · 2022: 14 · 2021: 20 · 2020: 14 · 2019: 19 · 2018: 20 · 2017: 9 · 2016: 1
FWCI
21.10
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Clinical Epigenetics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • publish.UP (University of Potsdam) (submittedVersion, cc-by)
  • publish.UP (University of Potsdam) (submittedVersion)
  • Refubium (Universitätsbibliothek der Freien Universität Berlin) (submittedVersion, cc-by)
  • Ubaya Repository (University of Surabaya) (submittedVersion)
  • Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver (cc-by)
Funders
Deutsche Forschungsgemeinschaft (Ho1665/5-2)
Topics
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
Keywords
gestational diabetes mellitus, placental DNA methylation, 5-methylcytosine, placenta, epigenetics, placental function, type 2 diabetes risk
MeSH terms
Adult, Female, Humans, Placenta, Pregnancy, Pregnancy Outcome, Cohort Studies, Logistic Models, Diabetes, Gestational, DNA Methylation, Epigenesis, Genetic, 5-Methylcytosine, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review